Suppr超能文献

RNA编辑酶ADAR1的亚型独立控制核酸传感器MDA5驱动的自身免疫和多器官发育。

Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.

作者信息

Pestal Kathleen, Funk Cory C, Snyder Jessica M, Price Nathan D, Treuting Piper M, Stetson Daniel B

机构信息

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195, USA.

Institute for Systems Biology, Seattle, WA 98195, USA.

出版信息

Immunity. 2015 Nov 17;43(5):933-44. doi: 10.1016/j.immuni.2015.11.001.

Abstract

Mutations in ADAR, which encodes the ADAR1 RNA-editing enzyme, cause Aicardi-Goutières syndrome (AGS), a severe autoimmune disease associated with an aberrant type I interferon response. How ADAR1 prevents autoimmunity remains incompletely defined. Here, we demonstrate that ADAR1 is a specific and essential negative regulator of the MDA5-MAVS RNA sensing pathway. Moreover, we uncovered a MDA5-MAVS-independent function for ADAR1 in the development of multiple organs. We showed that the p150 isoform of ADAR1 uniquely regulated the MDA5 pathway, whereas both the p150 and p110 isoforms contributed to development. Abrupt deletion of ADAR1 in adult mice revealed that both of these functions were required throughout life. Our findings delineate genetically separable roles for both ADAR1 isoforms in vivo, with implications for the human diseases caused by ADAR mutations.

摘要

编码ADAR1 RNA编辑酶的ADAR基因突变会导致Aicardi-Goutières综合征(AGS),这是一种与异常I型干扰素反应相关的严重自身免疫性疾病。ADAR1如何预防自身免疫尚不完全清楚。在此,我们证明ADAR1是MDA5-MAVS RNA传感途径的特异性和必需负调节因子。此外,我们发现ADAR1在多个器官发育中具有不依赖于MDA5-MAVS的功能。我们表明,ADAR1的p150亚型独特地调节MDA5途径,而p150和p110亚型都对发育有贡献。成年小鼠中ADAR1的突然缺失表明,这两种功能在整个生命过程中都是必需的。我们的研究结果描绘了ADAR1两种亚型在体内的基因可分离作用,这对由ADAR突变引起的人类疾病具有启示意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2196/4654992/52f88283ed00/nihms736550f1.jpg

相似文献

6
8
The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.RNA编辑酶ADAR1控制对RNA的先天免疫反应。
Cell Rep. 2014 Nov 20;9(4):1482-94. doi: 10.1016/j.celrep.2014.10.041. Epub 2014 Nov 13.

引用本文的文献

6
Interferons in human inborn errors of disease.人类先天性疾病中的干扰素。
mBio. 2025 Aug 13;16(8):e0157025. doi: 10.1128/mbio.01570-25. Epub 2025 Jun 24.
9
Emerging clinical applications of ADAR based RNA editing.基于ADAR的RNA编辑的新兴临床应用。
Stem Cells Transl Med. 2025 May 19;14(5). doi: 10.1093/stcltm/szaf016.

本文引用的文献

1
Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases.自身DNA激活环状GMP-AMP合酶会引发自身免疫性疾病。
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):E5699-705. doi: 10.1073/pnas.1516465112. Epub 2015 Sep 14.
4
Aicardi-Goutières syndrome and the type I interferonopathies.Aicardi-Goutières 综合征与Ⅰ型干扰素病。
Nat Rev Immunol. 2015 Jul;15(7):429-40. doi: 10.1038/nri3850. Epub 2015 Jun 5.
7
The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.RNA编辑酶ADAR1控制对RNA的先天免疫反应。
Cell Rep. 2014 Nov 20;9(4):1482-94. doi: 10.1016/j.celrep.2014.10.041. Epub 2014 Nov 13.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验